Current clinical trials for the treatment of idiopathic pulmonary fibrosis.
about
Overexpression of Sulf2 in idiopathic pulmonary fibrosisYear in review 2010: interstitial lung diseases, acute lung injury, sleep, physiology, imaging, bronchoscopic intervention and lung cancer.Deregulation of selective autophagy during aging and pulmonary fibrosis: the role of TGFβ1.Hydro-alcoholic extract of Raphanus sativus L. var niger attenuates bleomycin-induced pulmonary fibrosis via decreasing transforming growth factor β1 level.
P2860
Current clinical trials for the treatment of idiopathic pulmonary fibrosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current clinical trials for the treatment of idiopathic pulmonary fibrosis.
@en
Current clinical trials for the treatment of idiopathic pulmonary fibrosis.
@nl
type
label
Current clinical trials for the treatment of idiopathic pulmonary fibrosis.
@en
Current clinical trials for the treatment of idiopathic pulmonary fibrosis.
@nl
prefLabel
Current clinical trials for the treatment of idiopathic pulmonary fibrosis.
@en
Current clinical trials for the treatment of idiopathic pulmonary fibrosis.
@nl
P2093
P2860
P1433
P1476
Current clinical trials for the treatment of idiopathic pulmonary fibrosis.
@en
P2093
Joseph A Lasky
Ross C Klingsberg
Steven E Mutsaers
P2860
P356
10.1111/J.1440-1843.2009.01672.X
P577
2010-01-01T00:00:00Z